(Q38885032)

English

Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

0 references

0 references

0 references

0 references

Plasmodium falciparum

0 references

sulfadoxine/pyrimethamine

1 reference

based on heuristic

inferred from title

2

object named as

M R Kamya

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

3

object named as

G Dorsey

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

5

object named as

G Ndeezi

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

author name string

S G Staedke

1

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

A Gasasira

4

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

E D Charlebois

6

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

P J Rosenthal

7

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

language of work or name

0 references

publication date

1 August 2001

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

358

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

9279

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

368-374

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Challenges facing antimalarial therapy in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905557-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Malaria disaster in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905557-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of chloroquine resistance on malaria mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905557-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Averting a malaria disaster

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905557-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of amodiaquine and sulfadoxine-pyrimethamine as first-line treatment of falciparum malaria in Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905557-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic review of amodiaquine treatment in uncomplicated malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905557-X

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905557-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Can amodiaquine be resurrected?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905557-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Amodiaquine remains effective for treating uncomplicated malaria in west and central Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905557-X

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo efficacy study of amodiaquine and sulfadoxine/ pyrimethamine in Kibwezi, Kenya and Kigoma, Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905557-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The comparative efficacy of chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Kampala, Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905557-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of chloroquine, amodiaquine and pyrimethamine-sulphadoxine in Gambian children with uncomplicated malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905557-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Early clinical failures after pyrimethamine-sulfadoxine treatment of uncomplicated falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905557-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of artemisinin derivatives on malaria transmissibility

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905557-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Serious adverse drug reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905557-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimalarial drug resistance and combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905557-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology of drug resistance in malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905557-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905557-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905557-X

7 January 2021

based on heuristic

inferred from DOI database lookup

High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905557-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Sensitivity of Plasmodium falciparum in vivo to chloroquine and pyrimethamine-sulfadoxine in Rwandan patients in a refugee camp in Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905557-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(01)05557-X

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38885032&oldid=2039023537"